Search results
Dr. Jeff Hersh addresses cause, effects and complications of Graft vs Host Disease
The Metrowest Daily News via Yahoo News· 6 days agoGraft vs Host Disease occurs when white blood cells produced by donated stem cells identify the...
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector - npj...
Nature· 4 days agoWe then demonstrated that the effector functions of such Lenti-HPV-07-induced T cells synergize with anti-checkpoint inhibitory treatments by systemic administration of anti-TIM3 ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 days agoCommit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics PR Newswire AARHUS, Denmark, June 10, 2024 Commit Biologics is pioneering a novel approach to
Lighthouse Investment Partners LLC Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)
ETF DAILY NEWS· 3 days agoLighthouse Investment Partners LLC bought a new position in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with ...
Ultragenyx executive sells over $440k in company stock By Investing.com
Investing.com· 1 day agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) has reported a significant stock transaction by one of...
Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down to $12.17
ETF DAILY NEWS· 2 days agoViridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report)’s share price gapped down before the market opened on Monday . Viridian Therapeutics shares last traded at $11.94, with a volume of ...
Corbus Pharmaceuticals (NASDAQ:CRBP) Hits New 1-Year High Following Analyst Upgrade
ETF DAILY NEWS· 1 day agoCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) hit a new 52-week high on Wednesday after Royal Bank of Canada raised their price target on the stock from $77.00 to $82.00 ...
Opinion: San Diego's life sciences industry has long history of historic breakthroughs
U-T San Diego· 2 days agoPanetta is president and chief executive officer at Biocom California and lives in San Diego. Guerra...
Ultragenyx director Sanders Corazon sells $71,390 in company stock By Investing.com
Investing.com· 3 days agoThe shares were sold at a price of $41.10 each. Sanders Corazon, who serves as a director of...
Viridian Therapeutics (NASDAQ:VRDN) Receives Buy Rating from Needham & Company LLC
ETF DAILY NEWS· 2 days agoNeedham & Company LLC reissued their buy rating on shares of Viridian Therapeutics (NASDAQ:VRDN – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently ...